Covered recipient · General Payments record
RYAN BRUCE EMPEY
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2019–2024
$6,284.82
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $305.52 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $121.08 | 6 |
| Organon LLC | $47.69 | 3 |
| Biogen, Inc. | $45.06 | 3 |
| Sumitomo Pharma America, Inc. | $30.79 | 2 |
| Hologic Sales and Service, LLC | $25.14 | 1 |
| PFIZER INC. | $18.47 | 1 |
| SHIELD THERAPEUTICS INC | $17.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $18.47 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139262588 | CMS |
| Astellas Pharma US Inc | $23.98 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139288408 | CMS |
| Astellas Pharma US Inc | $25.63 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139272198 | CMS |
| Astellas Pharma US Inc | $14.58 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139335812 | CMS |
| Astellas Pharma US Inc | $17.13 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139403779 | CMS |
| Astellas Pharma US Inc | $21.29 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139431200 | CMS |
| Biogen, Inc. | $16.49 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104815923 | CMS |
| Biogen, Inc. | $14.02 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104845754 | CMS |
| Biogen, Inc. | $14.55 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104868606 | CMS |
| Hologic Sales and Service, LLC | $25.14 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084901300 | CMS |
| Organon Llc | $14.02 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136194358 | CMS |
| Organon Llc | $14.11 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136194354 | CMS |
| Organon Llc | $19.56 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136194356 | CMS |
| PFIZER INC. | $18.47 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131313909 | CMS |
| SHIELD THERAPEUTICS INC | $17.29 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150136787 | CMS |
| Sumitomo Pharma America, Inc. | $13.52 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148848867 | CMS |
| Sumitomo Pharma America, Inc. | $17.27 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148848869 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.